Incyte Corp
USPTO Trademark & Patent Filings
Trademark applications and grants for Incyte Corp. Incyte Corp has 41 trademark applications. The latest application filed is for "MPN HEROES"
| Patent Application | Date |
|---|---|
| IMIDAZOLE AND TRIAZOLE KRAS INHIBITORS 20220306633 - 17/700923 Qi; Chao ; et al. | 2022-09-29 |
| CRYSTALLINE SOLID FORMS OF A BET INHIBITOR 20220306628 - 17/830494 Chen; Shili ; et al. | 2022-09-29 |
| Salts of the Janus Kinase Inhibitor (R)-3-(4-(7h-Pyrrolo[2,3-D]Pyrimidin-4-YL)-1h-Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile 20220288078 - 17/536925 Li; Hui-Yin ; et al. | 2022-09-15 |
| SPIROCYCLIC LACTAMS AS JAK2 V617F INHIBITORS 20220281887 - 17/680002 Shepard; Stacey ; et al. | 2022-09-08 |
| RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS 20220280518 - 17/705624 Kuligowski; Michael ; et al. | 2022-09-08 |
| NCAGE Code | 1F8A9 | INCYTE CORPORATION |
| CAGE Code | 1F8A9 | INCYTE CORPORATION |
| S.A.M. Registration | 1F8A9 [556967347] | INCYTE CORPORATION |
| SEC | 0000879169 | INCYTE CORP of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 